IN2014CN02870A - - Google Patents

Info

Publication number
IN2014CN02870A
IN2014CN02870A IN2870CHN2014A IN2014CN02870A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A IN 2870CHN2014 A IN2870CHN2014 A IN 2870CHN2014A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A
Authority
IN
India
Prior art keywords
proteins
relates
kits used
diagnosis
therapeutic
Prior art date
Application number
Inventor
Oleg Melnyk
Laurent Raibaut
Vincent Aucagne
Agnès Delmas
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of IN2014CN02870A publication Critical patent/IN2014CN02870A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a method for assembling proteins from peptide fragments. Said method enables the production of proteins in a simple reliable manner that can be applied on an industrial scale. This method makes it possible to produce proteins with therapeutic or diagnostic value. The invention also relates to kits used for implementing said method for synthesizing proteins and to kits used in testing and/or diagnosis.
IN2870CHN2014 2011-10-17 2012-10-16 IN2014CN02870A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1159348A FR2981352B1 (en) 2011-10-17 2011-10-17 PROCESS FOR PROTEIN SYNTHESIS
PCT/EP2012/070454 WO2013057084A1 (en) 2011-10-17 2012-10-16 Method for synthesizing proteins

Publications (1)

Publication Number Publication Date
IN2014CN02870A true IN2014CN02870A (en) 2015-07-03

Family

ID=47022687

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2870CHN2014 IN2014CN02870A (en) 2011-10-17 2012-10-16

Country Status (10)

Country Link
US (1) US9206224B2 (en)
EP (1) EP2768842B1 (en)
JP (1) JP6321542B2 (en)
CN (1) CN103998455B (en)
CA (1) CA2852833A1 (en)
ES (1) ES2702786T3 (en)
FR (1) FR2981352B1 (en)
IN (1) IN2014CN02870A (en)
SG (1) SG11201401540WA (en)
WO (1) WO2013057084A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971509B1 (en) * 2011-02-16 2013-02-22 Centre Nat Rech Scient PROCESS FOR PREPARING PEPTIDES BY ASSEMBLING MULTIPLE PEPTIDE FRAGMENTS
US9359400B2 (en) * 2013-07-11 2016-06-07 Novartis Ag Site-specific chemoenzymatic protein modifications
NL2027769B1 (en) 2021-03-18 2022-09-29 Univ Delft Tech C-terminal peptide modification

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0832096B1 (en) 1995-05-04 2001-07-18 The Scripps Research Institute Synthesis of proteins by native chemical ligation
JP4358307B2 (en) 1996-12-24 2009-11-04 ザ スクリップス リサーチ インスティテュート General chemical bond
CA2292724A1 (en) * 1997-06-13 1998-12-17 Gryphon Sciences Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution
AU2001281463A1 (en) 2000-03-16 2001-09-24 The Regents Of The University Of California Chemoselective ligation
AU6153001A (en) 2000-05-12 2001-11-26 Wisconsin Alumni Res Found Ligation method and reagents to form an amide bond
US7884182B2 (en) 2001-11-14 2011-02-08 Amylin Pharmaceuticals, Inc. Chemical peptide ligation with three or more components
US20080108790A1 (en) * 2004-10-16 2008-05-08 Lonza Ag S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis
ES2326834T3 (en) * 2005-02-11 2009-10-20 Merck Patent Gmbh MARKING OF OLIGOSACARIDS IN THE SOLID PHASE: A TECHNIQUE FOR THE HANDLING OF IMMOBILIZED CARBOHYDRATES.
US7667076B2 (en) 2005-09-14 2010-02-23 Regents Of The University Of California Amide forming chemical ligation
FR2952058B1 (en) * 2009-10-29 2013-10-04 Centre Nat Rech Scient PROCESS FOR NATIVE LIGATION OF POLYPEPTIDES
CN102666565B (en) 2009-11-16 2016-01-20 国家科学研究中心 For the Compounds and methods for of the peptide that purifying is prepared by the solid phase method of peptide synthesis

Also Published As

Publication number Publication date
US9206224B2 (en) 2015-12-08
EP2768842A1 (en) 2014-08-27
ES2702786T3 (en) 2019-03-05
SG11201401540WA (en) 2014-06-27
US20140256879A1 (en) 2014-09-11
EP2768842B1 (en) 2018-07-25
JP2014532075A (en) 2014-12-04
CN103998455B (en) 2018-05-29
CA2852833A1 (en) 2013-04-25
JP6321542B2 (en) 2018-05-09
FR2981352B1 (en) 2015-07-03
FR2981352A1 (en) 2013-04-19
CN103998455A (en) 2014-08-20
WO2013057084A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
CY1120390T1 (en) COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES RELATING TO NURSES
EP4327885A3 (en) Antibody constructs for msln and cd3
EP4282484A3 (en) Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases
NZ760022A (en) Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor
MX2018009304A (en) Diagnostic and prognostic methods for cardiovascular diseases and events.
WO2014124334A3 (en) Transthyretin antibodies and uses thereof
NZ700823A (en) Antibodies against claudin 18.2 useful in cancer diagnosis
MX337535B (en) Antibody, kit and method for determining amyloid peptides.
EA201690213A1 (en) COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES
WO2014200912A3 (en) Mathematical processes for determination of peptidase cleavage
PH12017500489A1 (en) Human-derived anti-dipeptide repeats (dprs) antibody
EA201790438A1 (en) ANTIGEN-BINDING PROTEINS THAT CONNECT WITH CXCR5
MX358474B (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases.
BR112013024213A2 (en) medical instrument and method of manufacture
MX2016000393A (en) Lysine-specific chemoenzymatic protein modifications using microbial transglutaminase.
MX2016001719A (en) Methods and kits for predicting the risk of having a cardiovascular disease or event.
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
WO2014091490A3 (en) Diagnosis of autoimmune diseases using a specific antibody profile
EP2920595A4 (en) Method for the diagnostic of cancer and enzyme-linked immunoassay (elisa) kit for its application
TR201900550T4 (en) Antibody that binds a linear epitope of human p53 and its diagnostic applications.
WO2015001013A3 (en) Human anti-ifn-alpha antibodies
EP3696190A3 (en) Methods
IN2014CN02870A (en)
EA029703B9 (en) Novel allergen from ragweed pollen and uses thereof
EP3112867A4 (en) Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit